1. 跳轉至内容
  2. 跳轉至主選單
  3. 跳轉到更多DW網站

歐盟駐華商會表不滿

2013年9月5日
https://p.dw.com/p/19cKt
A security guard talks on his mobile phone as he patrols outside a GlaxoSmithKline factory in Shanghai July 16, 2013. China must crack down on commercial bribery by multinational firms, the country's top state paper said on Wednesday, two days after police accused British drugmaker GlaxoSmithKline of the widespread bribery of Chinese officials and doctors. Picture taken July 16, 2013. REUTERS/Stringer (CHINA - Tags: BUSINESS HEALTH CRIME LAW) CHINA OUT. NO COMMERCIAL OR EDITORIAL SALES IN CHINA
圖片來源: Reuters

北京

據德新社報導,歐盟駐華商會指責中國對歐洲企業採取歧視政策,不平等對待中、外企業。負責醫藥業的商會代表根斯布格爾(Bruno Gensburger)周四(9月5日)在北京指出,中方對在華外國醫藥生產商展開腐敗行為調查,但據他所知,迄今未對任何一家中國生產商進行相關調查。他稱,英國醫藥康采恩葛蘭素史克(GlaxoSmithKline)處於調查的中心,其他歐洲商人也成為當局的目標。根斯布格爾表示,任何形式的腐敗行為都必須受到打擊,但中外企業應適用同樣的標準。